X. Gu

Osimertinib versus afatinib in patients with T790M-positive, non-small-cell lung cancer and multiple central nervous system metastases after failure of initial EGFR-TKI treatment

Wei Sun, Yang Yang, Qilong Liu, 2021, BMC Pulmonary Medicine.

The Efficacy of Pyrotinib as a Third- or Higher-Line Treatment in HER2-Positive Metastatic Breast Cancer Patients Exposed to Lapatinib Compared to Lapatinib-Naive Patients: A Real-World Study

L. Guo, E. Zhou, L. Qian, 2021, Frontiers in Pharmacology.

Osimertinib versus afatinib in patients with T790M-positive, non-small-cell lung cancer and multiple central nervous system metastases after failure of initial EGFR-TKI treatment

Wei Sun, Yang Yang, Qilong Liu, 2019, BMC Pulmonary Medicine.

OTX1 silencing suppresses ovarian cancer progression through inhibiting the JAK/STAT signaling.

Qian Zhang, Q. Zhang, X. Gu, 2023, Tissue & cell.

Predictive significance of lymphocyte level and neutrophil‐to‐lymphocyte ratio values during radiotherapy in cervical cancer treatment

X. Gu, Xiaojing Yang, Shanshan Wang, 2023, Cancer medicine.